{"name":"Marian Macsai, MD","slug":"marian-macsai-md","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOY25aZVpfWDhxNGpUNWdZUXNmdzlULVZOZnBZQ3prbVEyVkV3VVJvQ18wc3R2OHcxcU9ZQjFpVzJDZUU3T2hVSnZLN09sQjA3TkIwR2NYZmxKandJMnVtYlJORHN5ZXRQZDFxMmZzdXJZWm5KaVJkOFhsall4WW1BRDRwUm1sTG0wWW9oMkdDQjJUalVQakJjUjdDaVBnT0Q2dGwtZjBpT1FPSVJiTlBIWTZ1UjNxSGRfTGpWOTl6Y0daYm5aNnc?oc=5","date":"2024-10-02","type":"pipeline","source":"Ophthalmology Times Europe","summary":"Novel therapies emerge for a progressive corneal disease - Ophthalmology Times Europe","headline":"Novel therapies emerge for a progressive corneal disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQeXM0TDB0YUZsalBmcmhlNDNoZDZWQU1ZTkNaMXRXdW1PYTFkMHVoTmZ4cWh1R3k0MnNzcGZ0S1pKTGgyTVl1dXNNWjA4dFFhNXFDRG80RUZ1VDBOakVmODMyTTQ4bnAtLUdBQVJGM3d0MGdXV0JQREVBT2JJcVgzU2Y1Rjd2T19lZ1NtWDl3WG14d3VKYTlWcWNzYVdpLVM2M3JjalhtaHNsR1ZEdm1aNTVGSzI4QQ?oc=5","date":"2022-05-20","type":"pipeline","source":"Healio","summary":"VIDEO: Marian Macsai, MD, provides eye health tips for women, part 2 - Healio","headline":"VIDEO: Marian Macsai, MD, provides eye health tips for women, part 2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxNcmRfMl93VUdfNzdLYVhPZHNMQi1VTV9tb213M2kyWE9YNUhZLWRXdFNFcEFqeUMwcWZrcUl0aUpZNm9sZ3BiRnFSbWExTGt1blBZaGhFU0h5Z3pEaXV6VFpqQ0c4MEdTUGNkUXhPakpsZC1fVEpHV2dtSmlvOXl3NGRR?oc=5","date":"2022-02-01","type":"pipeline","source":"Ophthalmology Times","summary":"Nasal spray treating dry eye disease - Ophthalmology Times","headline":"Nasal spray treating dry eye disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOblRNNEpzLV9ORTlwVl9CeHZfMmF2THBMak94ZFRTVlQwOFhyS1VTNzZZenI3Q2gyUXNaWktFaElrNHVkRi1FbEE4aGpwRnFsSkYydGFvVzZjX3l4a2xtN05NNkVpTVRteUVGZE5yYlRXa1ZiRXBNVm9saGMyWFg5eFBoa1lFZlQ2akN2LXNYblhUTjdaVGNSMVFmVmllSGRmd1YzMzEtekZwVm8?oc=5","date":"2021-11-15","type":"regulatory","source":"Ophthalmology Times","summary":"Varenicline nasal spray approved as a treatment for dry eye disease - Ophthalmology Times","headline":"Varenicline nasal spray approved as a treatment for dry eye disease","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE5VWXpHakN3Vi1JeUhmV190RElUVUVnYllqR1NpczEyaFZkTjIyNmdvc3k1N0J1MEM5SmdvMFB5VVJ6ZUtySG9Hd0I3ZHVPaU9nemYxbGJn?oc=5","date":"2021-10-22","type":"regulatory","source":"Medscape","summary":"FDA Approves First Nasal Spray for Dry Eye - Medscape","headline":"FDA Approves First Nasal Spray for Dry Eye","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxQTW9jMFdIbDREemlEd1VwN0hncHJFLUFPbzFBdU16QmRJVUZrc183RmtPQm9aVERYalowTHhzN1VmbGRaUUtlY181SkRzRE9jMGlYWjBUb3JqTGxQSVRUcG00X0N5V1VNWHJyMjJZWXV0R2o5NEk1TTZfeDBOR0hYeFc5OU9mb01TVm1Fd0tlVGRPMDUwdVpSVUFDU1RBSnM4b2NQVklHRkxUMV9aTWY3YWoyU2t3b0NYaG9zZlJNUQ?oc=5","date":"2021-06-21","type":"trial","source":"Ophthalmology Times","summary":"Oyster Point Pharma enrolls first subject in phase 2 clinical trial of OC-01 nasal spray for neurotrophic keratopathy - Ophthalmology Times","headline":"Oyster Point Pharma enrolls first subject in phase 2 clinical trial of OC-01 nasal spray for neurotrophic keratopathy","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}